{
    "code": "52027033",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027033",
    "time": "2020-02-07 03:05:08",
    "許可證字號": "衛部藥輸字第027033號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/01\/12",
    "發證日期": "106\/01\/12",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202703309",
    "中文品名": "大塚安立復錠2毫克",
    "英文品名": "OTSUKA ABILIFY Tablets 2mg",
    "適應症": "適應症：\r\n1.成人和青少年(13至17歲)的思覺失調症。\r\n2.成人和兒童(10至17歲)的雙極性疾患之躁症發作及混合型發作，可單獨使用或做為鋰鹽或Valproate的輔助治療。\r\n3.第一型雙極性疾患維持治療之鋰鹽或valproate的輔助治療。\r\n4.重鬱症之輔助治療。\r\n5.兒童(6至17歲)的自閉性疾患伴隨之急躁易怒。\r\n6.妥瑞氏症。",
    "劑型": "110錠劑",
    "包裝": "2~1000粒鋁箔盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1403301100  台灣大塚製藥股份有限公司",
        "申請商地址": "台北市中山區復興北路378號11樓",
        "主製造廠": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FKR0180100  KOREA OTSUKA PHARMACEUTICAL CO., LTD.",
            "製造廠廠址": "OTSUKA VISION BLDG., 226, YEOKSAM-RO, GANGNAM-GU, SEOUL 06227, KOREA",
            "製造廠公司地址": "",
            "製造廠國別": "KOREA",
            "製程": "公司"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200095400",
            "成分名稱": "ARIPIPRAZOLE",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Abilify Tablets _仿單 (IT0110)-106-01-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027033&Seq=001&Type=9"
        },
        {
            "title": "Abilify Tablets 2mg_Blister_final-106-01-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027033&Seq=002&Type=8"
        },
        {
            "title": "Abilify tablet 2 mg_Carton_final-106-01-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027033&Seq=001&Type=8"
        }
    ]
}